For 30 advance/early chapters : p atreon.com/AutumnXd
"You saw the news," Tom said. His voice was tired. He'd been up all night and was running on coffee and the kind of focus that only adrenaline can sustain. He yawned audibly into the phone.
"How serious is it for the company?" Ryan asked. "Cash flow okay?"
Tom didn't sound worried. There was the sound of him sipping something, probably tea or more coffee.
"Don't worry about the operations. I'll handle them. The suspension only stops new sales. It doesn't claw back the revenue we've already booked. That money is in the bank."
"As for cash position, we have several months of runway on hand. If we bring international revenue back to the domestic account, we extend further. And here's the kicker: I had three banks call me this morning offering credit lines. One zero-interest line, two low-interest. The suspension news is actually accelerating our financing options. Don't ask me why."
Tom's tone was steady throughout. Not a hint of panic.
"I've already started working the network to get the suspension lifted. This isn't going to drag on. The transparent absurdity of the complaint will help us. It'll be much harder for the agency to defend a six-month review when the underlying premise is 'mind control.'"
"The only real impact is on our expansion plans. I was negotiating to acquire two domestic prosthetics startups. NeuraPath we already closed. The other two are now on hold."
"NeuraPath plus our internal team is enough to run the v2 design without additional acquisitions," Ryan said. "Mason's group has the capacity. The other two startups can wait."
Tom continued with the operational update.
In the two months since the launch, Prism Sciences had completed approximately one thousand fittings domestically and over two thousand internationally. Domestic revenue was approaching one hundred million dollars. International revenue, in the same currency, was approaching another hundred million.
After taxes, the cash flow was supporting full operating expenses with margin to spare. And Prism Sciences was operating under a five-year tax exemption that the chairman had granted in exchange for Ryan's hold on the reactor patents. The exemption rounded out to approximately a hundred percent reduction in federal tax burden, with the possibility of extension for high-performing companies.
The tax exemption had been announced shortly after the Triton-1 launch. Several other domestic tech companies had been excited at the time, assuming the policy was a general one that they might also qualify for. The final list had been a single company: Prism Sciences.
Ryan absorbed the financial picture. The cash flow was healthy. The company wasn't going to fail. The suspension was an annoyance, not an existential threat.
He thought for a moment.
"International business is going to be hard while domestic operations are suspended. Maybe we focus expansion on countries with stable trade relationships with us. There are markets we haven't entered yet that don't have the same regulatory dependencies."
"Already on it. Leadership and I discussed exactly this last night. We're sending teams to evaluate three new markets within the next week."
Ryan tapped his fingers on the cafeteria table. Another idea was forming.
"Or," he said, "we bring foreign customers domestically."
"Wait. Sell to foreign customers but install here?"
"Right. International patients fly into our domestic fitting centers, get fitted here, fly home with their prosthetic installed. The local authorities can't suspend something that was sold and installed outside their borders. The customer comes home with a fitted prosthetic. Customs treats it as personal medical equipment, like a pacemaker or insulin pump. We supply parts to local partner centers for follow-up maintenance."
Tom paused. Ryan could hear him processing.
"Foreign patients traveling abroad for prosthetic care isn't unprecedented. Medical tourism is an established industry. People travel for cosmetic surgery, dental work, even joint replacement. Why not prosthetics?"
"And it sidesteps the suspension entirely. The agency can't regulate what they don't have jurisdiction over."
"Right. The product enters their country in the customer's possession, as personal medical equipment. The customer crosses customs with their prosthetic already installed. Nothing to declare. Nothing to seize. Just an amputee with a prosthetic."
"Is that... allowed?"
"It's not disallowed. People travel with medical implants all the time. There's no specific regulation prohibiting it. The agency would have to invent a new framework to stop it, which would take longer than our suspension hearing."
Tom laughed for the first time during the call. "I love this. We turn their attack into a marketing campaign. Foreign patients lining up to fly into the country for the prosthetic. Medical tourism inbound. The optics on this are going to be incredible."
"And every patient who travels here for fitting becomes a marketing testimonial when they return home."
"Genius. We'll start logistics planning this week. Coordinating airport pickup, hotel partnerships, expedited fitting schedules. I have a couple of friends in the travel industry who can move on this fast."
The conversation continued for a few more minutes. Tom was visibly more energized by the end of it. He'd entered the call exhausted and looking for reassurance. He'd left with a plan that turned the suspension into an opportunity.
"Talk soon," Tom said. "Don't worry about anything."
He hung up.
Ryan shook his head, smiling. His father's recovery time was always faster than expected.
A new message appeared on his phone. Chloe.
"Just saw the news. Is the company in trouble?"
Ryan settled back in his chair and replied with characteristic casualness.
"Not really. Just temporary inspection drama. Dad's already handling it. Nothing major."
He hit send and looked up.
Kyle was sitting at a nearby table, watching him with concern.
"I heard about the suspension. Is everything okay?"
Ryan rubbed his face. He'd been asked this question approximately five times since breakfast. He stood up, walked over to Kyle's table, and clapped him on the shoulder.
"It's fine. Stop worrying about it. By the way, I hear you've been working on a new research thread. How's that coming?"
The shift in topic landed exactly where Ryan had aimed. Kyle's face went through the same shade of green that a student's face goes through when their teacher asks about summer homework that was due last week.
"Uh."
"That bad?"
"It's coming along."
"Walk me through what you have."
Kyle started to walk through what he had, with the visible reluctance of someone who knew he was about to be inspected.
While Ryan was at the cafeteria conducting impromptu "homework checks," something significant was happening in the broader news cycle.
The National Disability Advocacy Organization (NDAO) released an announcement.
NDAO had committed two hundred million dollars to a new charitable initiative. The program, named the Lotus Initiative, would over the next five years fund prosthetic installations for up to twenty thousand domestic patients. The goal was to improve quality of life for disabled individuals while enabling them to participate more fully in the workforce and the broader economy.
NDAO was a domestic charitable advocacy organization with a quiet public profile. Most of the time, the organization's media presence was limited to occasional reports on accessibility legislation. NDAO rarely made national headlines except when there was a corruption scandal in the broader nonprofit sector.
Today, NDAO was the lead story on every news platform.
The announcement didn't name Prism Sciences specifically. But the timing was unmistakable. A two-hundred-million-dollar prosthetic funding program announced in the immediate aftermath of Triton-1's federal suspension was an obvious political signal. NDAO was telling the federal agency that there were institutional players who considered Triton-1 essential infrastructure for disabled Americans. NDAO was telling Helios that the regulatory attack had attracted countermoves from organizations with their own political weight.
The comments rolled in.
"Lotus Initiative? Okay, I see what NDAO is doing. Nicely played. Lotus, Triton, the symbolic flower of clarity vs. the messenger of the sea. Subtle, NDAO. Very subtle."
"This is a coordinated response. I love it."
"I was worried this might be the end of Prism Sciences. I'm less worried now."
"This is the kind of program that turns a regulatory issue into a political issue overnight. Helios is about to have a much harder time keeping their suspension intact."
"Disabled-affairs charity announcing two hundred million dollars to subsidize the product that just got suspended. The agency director is going to have a long week."
The Lotus Initiative was a public-policy weapon disguised as a charitable program. NDAO was making the political cost of maintaining the suspension significantly higher than it had been twenty-four hours earlier. The agency would now face questions not just from technology journalists but from disability advocates, civil rights organizations, and the segment of the political coalition that prioritized accessibility issues.
The suspension wasn't going to last six months. The suspension wasn't going to last six weeks.
Tom's friend, somewhere, had moved fast.